Vestor Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vestor Capital's ELV Position: Q2 2026 in Review
Vestor Capital reduced its Elevance Health (ELV) stake by 85% in Q2 2026, selling an estimated $522K and leaving 239 shares worth $187K. The position accounts for 0.01% of the portfolio, ranked #157.
Vestor Capital first reported a position in ELV in Q3 2021 and has held it in 20 quarters since. The position peaked at $12.5M in Q2 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vestor Capital held 239 shares of Elevance Health worth $187K as of Q2 2026.
- Vestor Capital sold 1,407 Elevance Health shares in Q2 2026, an estimated $522K.
- Elevance Health made up 0.01% of Vestor Capital's portfolio in Q2 2026, its #157 holding.
- Vestor Capital first reported a position in Elevance Health in Q3 2021 and has held it in 20 quarters since.
- Vestor Capital's Elevance Health position peaked at $12.5M in Q2 2022.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.